Implication of post-translationally modified SOD1 in pathological aging

Geroscience. 2021 Apr;43(2):507-515. doi: 10.1007/s11357-021-00332-2. Epub 2021 Feb 19.

Abstract

Why certain people relish healthy aging throughout their life span while others suffer pathological consequences? In this review, we focus on some of the dominant paradigms of pathological aging, such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD), and predict that the antioxidant superoxide dismutase 1 (SOD1), when post-translationally modified by aging-associated oxidative stress, acts as a mechanism to accelerated aging in these age-related neurodegenerative diseases. Oxidative modifications of natively reduced SOD1 induce pathological confirmations such as misfolding, leading to a subsequent formation of monomeric, oligomeric, and multimeric aggregates. Misfolded SOD1 propagates like prions from cell to cell. These modified conformations are detected in brain tissues in ALS, AD, and PD, and are considered a contributing factor to their initial pathogenesis. We have also elaborated on oxidative stress-induced non-native modifications of SOD1 and offered a logistic argument on their global implication in accelerated or pathological aging in the context of ALS, AD, and PD.

Keywords: Alzheimer’s disease (AD); Amyotrophic lateral sclerosis (ALS); Oxidative stress; Parkinson’s disease (PD); Pathological aging; Post-translational modification; SOD1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging / pathology*
  • Amyotrophic Lateral Sclerosis*
  • Humans
  • Parkinson Disease*
  • Protein Folding
  • Protein Processing, Post-Translational*
  • Superoxide Dismutase-1 / genetics*
  • Superoxide Dismutase-1 / metabolism

Substances

  • SOD1 protein, human
  • Superoxide Dismutase-1